Highlights of Ophthalmology

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Related articles

VOLUME 50 , ISSUE 5ESP ( October, 2022 ) > List of Articles

Dominio de la Progresión del Glaucoma Estructural

Alberto Diniz-Filho

Keywords : Glaucoma, glaucoma de ángulo abierto, tomografía de coherencia óptica, progresión

Citation Information : Diniz-Filho A. Dominio de la Progresión del Glaucoma Estructural. 2022; 50 (5ESP):17-25.

DOI: 10.5005/hos-10101-50503

Published Online: 29-09-2022

Copyright Statement:  Copyright © 2022; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

El glaucoma es una neuropatía óptica progresiva y su detección temprana es clave para prevenir la pérdida de visión derivada de la enfermedad. Muchos pacientes pueden mostrar cambios estructurales progresivos a pesar de la ausencia de pérdidas detectables en el campo visual. Estos cambios estructurales suelen cuantificarse mediante tecnologías de imagen, como la tomografía de coherencia óptica (OCT, por sus siglas en inglés). Esta tecnología puede proporcionar mediciones cuantitativas y reproducibles de la capa de fibras nerviosas de la retina peripapilar, la cabeza del nervio óptico y la mácula, que han demostrado ser útiles para la detección temprana de la progresión de la enfermedad. Por lo tanto, los oftalmólogos deben ser conscientes de cómo utilizar adecuadamente las herramientas de progresión proporcionadas por la OCT.


PDF Share
  1. Sommer A, Katz J, Quigley HA, et al. Clinically detectable nerve fiber atrophy precedes the onset of glaucomatous field loss. Arch Ophthalmol. 1991;109:77-83.
  2. Kuang TM, Zhang C, Zangwill LM, et al. Estimating lead time gained by optical coherence tomography in detecting glaucoma before development of visual field defects. Ophthalmology. 2015;122:2002-9.
  3. Medeiros FA, Alencar LM, Zangwill LM, et al. Prediction of functional loss in glaucoma from progressive optic disc damage. Arch Ophthalmol. 2009;127:1250-6.
  4. Gracitelli CP, Abe RY, Tatham AJ, et al. Association between progressive retinal nerve fiber layer loss and longitudinal change in quality of life in glaucoma. JAMA Ophthalmol. 2015;133:384-90.
  5. Wollstein G, Schuman JS, Price LL, et al. Optical coherence tomography longitudinal evaluation of retinal nerve fiber layer thickness in glaucoma. Arch Ophthalmol. 2005;123:464-70.
  6. Grewal DS, Tanna AP. Diagnosis of glaucoma and detection of glaucoma progression using spectral domain optical coherence tomography. Curr Opin Ophthalmol. 2013;24:150-61.
  7. Leung CK. Diagnosing glaucoma progression with optical coherence tomography. Curr Opin Ophthalmol. 2014;25:104-11.
  8. Abe RY, Gracitelli CP, Medeiros FA. The use of spectral-domain optical coherence tomography to detect glaucoma progression. Open Ophthalmol J. 2015;9:78-88.
  9. Tatham AJ, Medeiros FA. Detecting Structural Progression in Glaucoma with Optical Coherence Tomography. Ophthalmology. 2017;124:S57-65.
  10. Huang D, Swanson EA, Lin CP, et al. Optical coherence tomography. Science. 1991;254:1178-81.
  11. Medeiros FA, Zangwill LM, Alencar LM, et al. Detection of glaucoma progression with stratus OCT retinal nerve fiber layer, optic nerve head, and macular thickness measurements. Invest Ophthalmol Vis Sci. 2009;50:5741-8.
  12. Leung CK, Cheung CY, Weinreb RN, et al. Retinal nerve fiber layer imaging with spectral-domain optical coherence tomography: a variability and diagnostic performance study. Ophthalmology. 2009;116:1257-63.
  13. Abe RY, Diniz-Filho A, Zangwill LM, et al. The Relative Odds of Progressing by Structural and Functional Tests in Glaucoma. Invest Ophthalmol Vis Sci. 2016;57: OCT 421-8.
  14. Belghith A, Bowd C, Medeiros FA, et al. Does the Location of Bruch's Membrane Opening Change Over Time? Longitudinal Analysis Using San Diego Automated Layer Segmentation Algorithm (SALSA). Invest Ophthalmol Vis Sci. 2016;57:675-82.
  15. Vianna JR, Danthurebandara VM, Sharpe GP, et al. Importance of normal aging in estimating the rate of glaucomatous neuroretinal rim and retinal nerve fiber layer loss. Ophthalmology. 2015;122:2392-8.
  16. Leung CK, Yu M, Weinreb RN, et al. Retinal nerve fiber layer imaging with spectral-domain optical coherence tomography: patterns of retinal nerve fiber layer progression. Ophthalmology. 2012;119:1858-66.
  17. Lee WJ, Kim YK, Park KH, Jeoung JW. Trend-based Analysis of Ganglion Cell-Inner Plexiform Layer Thickness Changes on Optical Coherence Tomography in Glaucoma Progression. Ophthalmology. 2017;124:1383-91.
  18. Thompson AC, Jammal AA, Medeiros FA. Performance of the Rule of 5 for Detecting Glaucoma Progression between Visits with OCT. Ophthalmol Glaucoma. 2019;2:319-26.
  19. Thompson AC, Jammal AA, Berchuck SI, et al. Comparing the Rule of 5 to Trend-based Analysis for Detecting Glaucoma Progression on OCT. Ophthalmol Glaucoma. 2020;3:414-20.
  20. Leung CK, Yu M, Weinreb RN, et al. Retinal nerve fiber layer imaging with spectral-domain optical coherence tomography: a prospective analysis of age-related loss. Ophthalmology. 2012;119:731-7.
  21. Wu Z, Saunders LJ, Zangwill LM, et al. Impact of Normal Aging and Progression Definitions on the Specificity of Detecting Retinal Nerve Fiber Layer Thinning. Am J Ophthalmol. 2017;181:106-13.
  22. Mwanza JC, Kim HY, Budenz DL, et al. Residual and Dynamic Range of Retinal Nerve Fiber Layer Thickness in Glaucoma: Comparison of Three OCT Platforms. Invest Ophthalmol Vis Sci. 2015;56:6344-51.
  23. Lavinsky F, Wu M, Schuman JS, et al. Can Macula and Optic Nerve Head Parameters Detect Glaucoma Progression in Eyes with Advanced Circumpapillary Retinal Nerve Fiber Layer Damage? Ophthalmology. 2018;125:1907-12.
  24. Diniz-Filho A, Abe RY, Zangwill LM, et al. Association between intraocular pressure and rates of retinal nerve fiber layer loss measured by optical coherence tomography. Ophthalmology. 2016;123:2058-65.
  25. Jammal AA, Thompson AC, Mariottoni EB, et al. Impact of Intraocular Pressure Control on Rates of Retinal Nerve Fiber Layer Loss in a Large Clinical Population. Ophthalmology. 2021;128:48-57.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.